Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Biological Sciences|March 27, 2020
Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imagingLavinia Morosi, Cristina Matteo, Tommaso Ceruti, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2003
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studiesDaniela Meco, Tina Colombo, Paolo Ubezio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesisElitza Naumova, Paolo Ubezio, Angela Garofalo, et al.
Analytica Chimica Acta|November 16, 2018
Past-in-the-Future. Peak detection improves targeted mass spectrometry imagingFrancesca Falcetta, Lavinia Morosi, Paolo Ubezio, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 22, 2011
Interoperability of time series cytometric data: a cross platform approach for modeling tumor heterogeneityImtiaz A Khan, Monica Lupi, Lee Campbell, et al.
Macromolecular Bioscience|July 27, 2018
Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer ExcipientsUmberto Capasso Palmiero, Lavinia Morosi, Monica Lupi, et al.
Investigational New Drugs|June 3, 2011
Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical modelsAngela Maria Di Francesco, Paolo Ubezio, Anna Rita Torella, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapiesKatiuscia Bonezzi, Dorina Belotti, Brian J North, et al.
Oncogene|December 13, 2018
HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive casesGabriela Paroni, Marco Bolis, Adriana Zanetti, et al.
Cancer Chemotherapy and Pharmacology|August 28, 2013
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinibMassimo Zucchetti, Katiuscia Bonezzi, Roberta Frapolli, et al.
Pageof 6